Search results
Results from the WOW.Com Content Network
Novartis fought a seven-year, controversial battle to patent Gleevec in India, and took the case all the way to the Indian Supreme Court, where the patent application was finally rejected. The patent application at the center of the case was filed by Novartis in India in 1998, after India had agreed to enter the World Trade Organization and to ...
Novartis v. Union of India & Others is a landmark decision by a two-judge bench of the Indian Supreme Court on the issue of whether Novartis could patent Gleevec in India, and was the culmination of a seven-year-long litigation fought by Novartis. The Supreme Court upheld the Indian patent office's rejection of the patent application.
Rank Brand Name(s) Generic Name Sales Q1 2014 Sales ($000) Change from Q4 2013 Company(ies) Disease/Medical Use First Approval Date Patent Expiration Date [6] [7]; 1: Abilify
Novartis AG for innovation in treatments for drug-resistant tuberculosis, donated to the TB Alliance; Sanitation. American Standard Brands – for SaTo, a safe toilet; Nutrition. Golden rice – a strain of rice high in beta-carotene to reduce Vitamin A deficiency. Nutriset – manufacturer of Plumpy'nut, a peanut-based paste to treat ...
The 100 known most prolific inventors based on worldwide utility patents are shown in the following table. While in many cases this is the number of utility patents granted by the United States Patent and Trademark Office, it may include utility patents granted by other countries, as noted by the source references for an inventor.
Novartis had filed a patent for Glivec in 1997. [30] An exclusive marketing right was also granted for Novartis in 2003 and the application were approved in 2005 . [ 30 ] In 2013, the Supreme Court of India upheld the rejection of the patent application of Glivec by Novartis , [ 31 ] ending the 10-years battle between the proprietary drug ...
Its core businesses involve patented drugs, generic drugs, eye protection drugs and health products. Novartis Beijing was founded by Novartis AG and Beijing Pharmaceutical group and Beijing Zizhu Pharmaceuticals in 1987, the first foreign pharmaceutical company in China. Sanofi-Aventis The German-French company sells several drugs in China ...
In a filing to the FDA, Novartis said that two executives, brothers Brian and Allan Kaspar manipulated the data, pressured others into manipulating data and then attempted to cover it up. [ 36 ] [ 35 ] Novartis fired the executives it deemed responsible for the data manipulation but informed the FDA of the data integrity issue only in June 2019 ...